Gravity Co., Ltd. (NASDAQ:GRVY – Get Free Report) was the recipient of a large growth in short interest in the month of November. As of November 30th, there was short interest totalling 36,400 shares, a growth of 93.6% from the November 15th total of 18,800 shares. Based on an average daily volume of 31,500 shares, the short-interest ratio is presently 1.2 days.
Wall Street Analysts Forecast Growth
Separately, StockNews.com raised Gravity from a “hold” rating to a “buy” rating in a research report on Thursday, November 14th.
Get Our Latest Stock Analysis on GRVY
Hedge Funds Weigh In On Gravity
Gravity Stock Performance
Shares of NASDAQ GRVY traded down $1.13 during mid-day trading on Friday, reaching $65.78. The company had a trading volume of 30,790 shares, compared to its average volume of 32,613. Gravity has a one year low of $57.37 and a one year high of $88.85. The business’s 50-day simple moving average is $64.79 and its 200 day simple moving average is $69.31. The firm has a market cap of $457.17 million, a price-to-earnings ratio of 7.33 and a beta of 1.32.
About Gravity
Gravity Co, Ltd. develops and publishes online and mobile games worldwide. It offers a massively multiplayer online role-playing game, including Ragnarok Online, Dragonica, Ragnarok Online II, and Ragnarok Landverse. Its mobile games portfolio includes Ragnarok M; Eternal Love; Ragnarok Origin; Ragnarok X: Next Generation; Ragnarok Arena; WITH ISLAND; the Labyrinth of Ragnarok; Ragnarok Poring Merge; Tera Classic; Ragnarok: The Lost Memories; Sadako M; NBA: Rise To Stardom; Milkmaid Of The Milky Way; Generation Zombie; Ragnarok Idle Adventure; Ragnarok 20 Heroes; White Chord; WITH: Whale In The High; Ragnarok Lost Memories; and Paladog Tactics.
Featured Articles
- Five stocks we like better than Gravity
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- How to Read Stock Charts for Beginners
- Texas Instruments: The Old-School Tech Titan Still Delivering
- How to Capture the Benefits of Dividend Increases
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Gravity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gravity and related companies with MarketBeat.com's FREE daily email newsletter.